𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Sensorineural hearing loss in sickle cell disease—A prospective study from Oman

✍ Scribed by Muhammed Hesham Al Okbi; Salam Alkindi; Rashid K. Al Abri; John Mathew; Afarida A. Nagwa; Anil V. Pathare

Publisher
John Wiley and Sons
Year
2011
Tongue
English
Weight
622 KB
Volume
121
Category
Article
ISSN
0023-852X

No coin nor oath required. For personal study only.

✦ Synopsis

Abstract

Background:

Sickle cell disease (SCD) is characterized by intermittent episodes of vascular occlusion and end‐organ damage. Neurologic symptoms are frequent and auditory involvement is not unexpected.

Aim:

To study the prevalence and pattern of hearing loss in Omani patients with SCD.

Methods:

We conducted a prospective case control study on SCD patients attending the outpatient department. Age and sex matched normal volunteer blood donor controls were recruited after an informed consent and Medical Ethics Committee approval. Pure tone audiometry was performed in all cases studied.

Results:

Forty‐six SCD patients (15 males, 32.6%) aged 16–45 years with a mean age of 26 years ± 6.9 and 29 controls (10 males, 34.4%) aged 16–39 years with a mean age of 25.24 ± 8.2 were enrolled in this study. The average hearing thresholds of SCD patients were consistently higher than controls in all frequencies tested in both ears. Of the 92 ears tested in SCD patients, 29.34% had SNHL. Ten patients had bilateral SNHL; whereas 3 and 4 cases had SNHL in left and right ears, respectively. All the control subjects had hearing thresholds within normal limits.

Summary/Conclusions:

The study reveals a significant incidence of sensorineural hearing loss (SNHL) in SCD patients (36.95%), although the patients were clinically asymptomatic. The hearing loss was worse in the right ears and had a female preponderance. Also, the hearing loss was more severe at the higher frequencies, 2,000–8,000 Hz in SCD patients. HbS, HbF, or low hemoglobin levels did not discriminate SCD patients with SNHL, and the role of hemoglobin F in the cochlea is still not clear. Regular audiometric assessment should therefore be recommended in SCD patients routinely. Laryngoscope, 2011

📜 SIMILAR VOLUMES

Treatment with HELP-apheresis in patient
Treatment with HELP-apheresis in patients suffering from sudden sensorineural hearing loss: A prospective, randomized, controlled study
✍ Giovanni Bianchin; Gianpaolo Russi; Nicola Romano; Paola Fioravanti 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 105 KB

## Abstract ## Objectives/Hypothesis: This study's aim was to verify whether, in patients affected by sudden sensorineural hearing loss (SSHL) with high plasmatic levels of low‐density–lipoprotein (LDL) cholesterol and/or fibrinogen, the therapeutic approach with a single selective plasmapheresis

Long-term sensorineural hearing deficit
Long-term sensorineural hearing deficit following radiotherapy in patients suffering from nasopharyngeal carcinoma: A prospective study
✍ Wai-kuen Ho; William I. Wei; Dora L.W. Kwong; Jonathan S.T. Sham; Patricia T.H. 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 86 KB 👁 2 views

Background. This was a prospective study to evaluate the effect of radical external irradiation on inner ear function after treatment of nasopharyngeal carcinoma. Methods. Pure tone audiograms were performed at regular intervals before, after, and up to 4.5 years following completion of radiothera

Morbidity and mortality in chronically t
Morbidity and mortality in chronically transfused subjects with thalassemia and sickle cell disease: A report from the multi-center study of iron overload
✍ Ellen B. Fung; Paul Harmatz; Meredith Milet; Samir K. Ballas; Laura De Castro; W 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 190 KB 👁 2 views

## Abstract A natural history study was conducted in 142 Thalassemic (Thal), 199 transfused Sickle Cell Disease (Tx‐SCD, __n__ = 199), and 64 non‐Tx‐SCD subjects to describe the frequency of iron‐related morbidity and mortality. Subjects recruited from 31 centers in the US, Canada or the UK were si